Medifast (MED) Retained Earnings (2010 - 2026)

Medifast's Retained Earnings history runs 17 years deep, the most recent figure standing at $41.5 million for Q1 2026.

• Quarterly Retained Earnings rose 19.57% year-over-year to $41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.5 million (up 19.57% YoY) and the FY2025 annual result came in at $158.3 million, down 10.47% from the prior year.
• Retained Earnings was $41.5 million for Q1 2026 at Medifast, down from $158.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at $203.1 million in Q1 2022 and bottomed at $24000.0 in Q4 2022.
• A 5-year average of $81.5 million and a median of $34.7 million in 2025 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings tumbled 99.99% — and 2023, when it jumped 727604.17%.
• Medifast's Retained Earnings stood at $24000.0 in 2022, then soared by 727604.17% to $174.6 million in 2023, then climbed by 1.22% to $176.8 million in 2024, then retreated by 10.47% to $158.3 million in 2025, then slumped by 73.79% to $41.5 million in 2026.
• Business Quant data shows MED's Retained Earnings at $41.5 million in Q1 2026, $158.3 million in Q4 2025, and $220000.0 in Q3 2025.